Analyze Diet
Veterinary sciences2026; 13(2); 121; doi: 10.3390/vetsci13020121

Identifying Host-Characteristics and Management Risk Factors in a California Equine Herpesvirus Myeloencephalopathy (EHM) Outbreak.

Abstract: Equine alphaherpesvirus-1 (EHV-1) is a highly contagious virus that can cause the neurological form, equine herpesvirus myeloencephalopathy (EHM). Understanding transmission-related risk factors is crucial for improving prevention strategies and guiding effective control measures. In this study, we collected data from 63 horses that had previously participated in the February 2022 winter horse show season at the Desert International Horse Park (DIHP) (26 cases and 37 controls) to identify host and management factors associated with EHV-1 infection and/or EHM development during the February 2022 outbreak at the DIHP in Thermal, California. Risk factors were evaluated using multivariable logistic regression and a random forest model with conditional permutation importance. Greater age was associated with higher odds of becoming a case (OR = 1.33; 95%CI: 1.04-1.69, -value: 0.01). Compared with hunters, jumpers had greater odds of developing EHV-1 and/or EHM (OR = 7.37; 95%CI: 1.57-34.61, -value: 0.01). Sharing a barn was also strongly associated with EHV-1 and/or EHM case status (OR = 7.37; 95%CI: 1.79-30.29, -value: <0.01). The machine-learning-based rankings were concordant with the regression estimates. Age, main activity, and sharing a barn were the most influential risk factors associated with elevated odds of developing EHV-1 and/or EHM. These results highlight specific demographic and management-related risk factors that could inform targeted prevention strategies.
Publication Date: 2026-01-27 PubMed ID: 41745915PubMed Central: PMC12944867DOI: 10.3390/vetsci13020121Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the factors related to horse characteristics and management practices that influenced the risk of equine herpesvirus myeloencephalopathy (EHM) during an outbreak at a horse show in California.
  • The goal was to identify which factors increased the likelihood of horses contracting EHV-1 and developing EHM, to help guide better prevention and control measures.

Background on EHV-1 and EHM

  • Equine alphaherpesvirus-1 (EHV-1) is a contagious virus affecting horses.
  • One severe manifestation is equine herpesvirus myeloencephalopathy (EHM), a neurological disease causing significant illness.
  • Understanding how the virus spreads and what host or management factors contribute to infection and disease development is critical for disease control.

Study Context and Data Collection

  • The study focused on a 2022 outbreak at the Desert International Horse Park (DIHP) in Thermal, California.
  • Data were collected from 63 horses who attended a winter horse show season in February 2022.
  • Among these horses, 26 were infected or developed EHM (cases), and 37 remained uninfected (controls).
  • Researchers collected detailed information on horse demographics and management factors to assess which factors were linked to infection and disease.

Analytical Methods

  • Two main quantitative approaches were used:
    • Multivariable logistic regression to estimate odds ratios (ORs) for risk factors.
    • Machine learning via a random forest model with conditional permutation importance to rank variable influence.
  • These complementary approaches allowed the researchers to validate findings and identify the most impactful factors.

Key Findings on Risk Factors

  • Age: Older horses had significantly higher odds of becoming infected or developing EHM.
    • Each incremental increase in age raised the odds by about 33% (OR = 1.33).
  • Main Activity: The type of equestrian activity was linked to risk.
    • Jumpers were over 7 times more likely to become cases compared to hunters (OR = 7.37).
  • Management – Barn Sharing: Horses sharing a barn had markedly increased odds of infection/EHM (OR = 7.37).
    • This highlights close contact through shared housing as a key transmission route.

Interpretation of Results

  • The concordance between the logistic regression and machine learning models strengthens confidence in these findings.
  • Age, type of equestrian activity, and barn sharing emerged as the most influential risk factors.
  • These factors suggest that older horses, those involved in jumping, and those housed closely with others face greater risk during an outbreak.

Implications for Prevention and Control

  • Targeted prevention strategies can focus on:
    • Minimizing close contact in barns during outbreaks, possibly by isolating horses or limiting shared housing.
    • Special monitoring and biosecurity for older horses and those involved in jump activities.
    • Adjustments in management practices during horse shows or competitions to reduce spread.
  • Understanding these risk factors helps veterinarians and horse managers tailor approaches to limit EHV-1 transmission and reduce the incidence of EHM.

Cite This Article

APA
Gordon S, Pusterla N, Finno CJ, Young A, Martínez-López B. (2026). Identifying Host-Characteristics and Management Risk Factors in a California Equine Herpesvirus Myeloencephalopathy (EHM) Outbreak. Vet Sci, 13(2), 121. https://doi.org/10.3390/vetsci13020121

Publication

ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 13
Issue: 2
PII: 121

Researcher Affiliations

Gordon, Shadira
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Pusterla, Nicola
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Finno, Carrie J
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • Center for Equine Health, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Young, Amy
  • Center for Equine Health, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Martínez-López, Beatriz
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

Grant Funding

  • 2021-68014-34143 / Agriculture and Food Research Initiative Competitive Grant

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 45 references
  1. Laval K, Poelaert KCK, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1. Front. Microbiol. 2021;12:662686.
    doi: 10.3389/fmicb.2021.662686pmc: PMC7970122pubmed: 33746936google scholar: lookup
  2. Bryant NA, Wilkie GS, Russell CA, Compston L, Grafham D, Clissold L, McLay K, Medcalf L, Newton R, Davison AJ. Genetic diversity of equine herpesvirus 1 isolated from neurological, abortigenic, and respiratory disease outbreaks. Transbound. Emerg. Dis. 2018;65:817–832.
    doi: 10.1111/tbed.12809pmc: PMC5947664pubmed: 29423949google scholar: lookup
  3. Ahdy AM, Ahmed BM, Elgamal MA, Shaalan M, Farag IM, Mahfouz ER, Darwish HR, Sayed-Ahmed MZ, Shalaby MA, El-Sanousi AA. Detection of Equid Alphaherpesvirus 1 from Arabian Horses with different clinical presentations between 2016-2019 in Egypt. J. Equine Vet. Sci. 2022;114:103960.
    doi: 10.1016/j.jevs.2022.103960pubmed: 35430231google scholar: lookup
  4. Sprayberry KA, Robinson NE. Robinson’s Current Therapy in Equine Medicine. 7th ed. Saunders; St Louis, MO, USA: 2015.
    doi: 10.1016/C2011-0-05761-7google scholar: lookup
  5. Eady NA, Holmes C, Schnabel C, Babasyan S, Wagner B. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies. J. Virol. 2024;98:e0025024.
    doi: 10.1128/jvi.00250-24pmc: PMC11237562pubmed: 38742875google scholar: lookup
  6. Allen GP. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am. J. Vet. Res. 2008;69:1595–1600.
    doi: 10.2460/ajvr.69.12.1595pubmed: 19046006google scholar: lookup
  7. de la Cuesta-Torrado M, Velloso Alvarez A, Santiago-Llorente I, Armengou L, Nieto F, Ríos J, Cruz-López F, Jose-Cunilleras E. Risk Factors and Long-Term Outcomes in Horses After the 2021 Outbreak of Equine Herpesvirus 1 Myeloencephalopathy, Valencia, Spain. J. Vet. Intern. Med. 2025;39:e70040.
    doi: 10.1111/jvim.70040pmc: PMC11888933pubmed: 40055829google scholar: lookup
  8. Traub-Dargatz JL, Pelzel-McCluskey AM, Creekmore LH, Geiser-Novotny S, Kasari TR, Wiedenheft AM, Bush EJ, Bjork KE. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak. J. Vet. Intern. Med. 2013;27:339–346.
    doi: 10.1111/jvim.12051pubmed: 23398291google scholar: lookup
  9. Klouth E, Zablotski Y, Petersen JL, de Bruijn M, Gröndahl G, Müller S, Goehring LS. Epidemiological Aspects of Equid Herpesvirus-Associated Myeloencephalopathy (EHM) Outbreaks. Viruses 2022;14:2576.
    doi: 10.3390/v14112576pmc: PMC9695031pubmed: 36423188google scholar: lookup
  10. Lunn DP, Burgess BA, Dorman DC, Goehring LS, Gross P, Osterrieder K, Pusterla N, Soboll Hussey G. Updated ACVIM consensus statement on equine herpesvirus-1. J. Vet. Intern. Med. 2024;38:1290–1299.
    doi: 10.1111/jvim.17047pmc: PMC11099706pubmed: 38497217google scholar: lookup
  11. Allen G. Respiratory infections by equine herpesvirus types 1 and 4. In: Lekeux P., editor. Equine Respiratory Diseases. International Veterinary Information Service; Ithaca, NY, USA: 2002.
  12. Edington N, Welch HM, Griffiths L. The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet. J. 1994;26:140–142.
  13. Borchers K, Thein R, Sterner-Kock A. Pathogenesis of equine herpesvirus-associated neurological disease: A revised explanation. Equine Vet. J. 2006;38:283–287.
    doi: 10.2746/042516406776866462pubmed: 16706288google scholar: lookup
  14. Kilby ER. The demographics of the U.S. equine population. In: Salem DJ, Rowan AN, editors. The State of the Animals. Humane Society Press; Washington, DC, USA: 2007. pp. 175–205.
  15. Fédération Equestre Internationale (2025, January 28). Master List: 2025_CI_0135—Thermal, CA (CSI5-W/CSI2*) [(accessed on 10 November 2025)]. Available online: https://www.worldofshowjumping.com/Htdocs/Files/v/7325.pdf/2025_CI_0135_masterlist.pdf.
  16. United States Equestrian Federation (2025, July 15). 2025 U.S. FEI Jumping Calendar [PDF] [(accessed on 10 November 2025)]. Available online: https://files.usef.org/assets/2OY4q_ZwL80/2025-fei-jumping-calendar-oct-22.pdf.
  17. Oladunni F.S., Horohov D.W., Chambers T.M.. EHV-1: A Constant Threat to the Horse Industry. Front. Microbiol. 2019;10:2668.
    doi: 10.3389/fmicb.2019.02668pmc: PMC6901505pubmed: 31849857google scholar: lookup
  18. Lunn D.P., Davis-Poynter N., Flaminio M.J., Horohov D.W., Osterrieder K., Pusterla N., Townsend H.G.. Equine herpesvirus-1 consensus statement. J. Vet. Intern. Med. Am. Coll. Vet. Intern. Med. 2009;23:450–461.
  19. O’Callaghan D.J., Osterrieder N.. Herpesviruses of Horses. Encyclopedia of Virology 3rd ed. Academic Press; Cambridge, MA, USA: 2008; pp. 411–420.
  20. Pusterla N., Hussey G.S.. Equine herpesvirus 1 myeloencephalopathy. The Veterinary clinics of North America. Equine Pract. 2014;30:489–506.
    doi: 10.1016/j.cveq.2014.08.006pubmed: 25300635google scholar: lookup
  21. Couroucé A., Normand C., Tessier C., Pomares R., Thévenot J., Marcillaud-Pitel C., Legrand L., Pitel P.H., Pronost S., Lupo C.. Equine Herpesvirus-1 Outbreak During a Show-Jumping Competition: A Clinical and Epidemiological Study. J. Equine Vet. Sci. 2023;128:104869.
    doi: 10.1016/j.jevs.2023.104869pubmed: 37339699google scholar: lookup
  22. Pronost S., Legrand L., Pitel P.H., Wegge B., Lissens J., Freymuth F., Richard E., Fortier G.. Outbreak of equine herpesvirus myeloencephalopathy in France: A clinical and molecular investigation. Transbound. Emerg. Dis. 2012;59:256–263.
  23. Dean A.G., Sullivan K.M., Soe M.M.. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. [(accessed on 10 June 2025)].
  24. Textor J., van der Zander B., Gilthorpe M.S., Liskiewicz M., Ellison G.T.. Robust causal inference using directed acyclic graphs: The R package ‘dagitty’. Int. J. Epidemiol. 2016;45:1887–1894.
    doi: 10.1093/ije/dyw341pubmed: 28089956google scholar: lookup
  25. Shrier I., Platt R.W.. Reducing bias through directed acyclic graphs. BMC Med. Res. Methodol. 2008;8:70.
    doi: 10.1186/1471-2288-8-70pmc: PMC2601045pubmed: 18973665google scholar: lookup
  26. SAS Institute Inc. SAS/STAT 15.2 User’s Guide. SAS Institute Inc.; Cary, NC, USA: 2022.
  27. Weng H.Y., Hsueh Y.H., Messam L.L., Hertz-Picciotto I.. Methods of covariate selection: Directed acyclic graphs and the change-in-estimate procedure. Am. J. Epidemiol. 2009;169:1182–1190.
    doi: 10.1093/aje/kwp035pubmed: 19363102google scholar: lookup
  28. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2021 [(accessed on 23 January 2026)].
  29. Cordeiro G.M., McCullagh P.. Bias Correction in Generalized Linear Models. J. R. Stat. Soc. Ser. B (Methodol.) 1991;53:629–643.
  30. Maiti T, Pradhan V. A comparative study of the bias corrected estimates in logistic regression. Stat. Methods Med. Res. 2008;17:621–634.
    doi: 10.1177/0962280207084156pubmed: 18375454google scholar: lookup
  31. Mansournia M.A., Geroldinger A., Greenland S., Heinze G. Separation in Logistic Regression: Causes, Consequences, and Control. Am. J. Epidemiol. 2018;187:864–870.
    doi: 10.1093/aje/kwx299pubmed: 29020135google scholar: lookup
  32. Strobl C., Boulesteix A.L., Kneib T., Augustin T., Zeileis A. Conditional variable importance for random forests. BMC Bioinform. 2008;9:307.
    doi: 10.1186/1471-2105-9-307pmc: PMC2491635pubmed: 18620558google scholar: lookup
  33. Goehring L.S., van Winden S.C., van Maanen C., Sloet van Oldruitenborgh-Oosterbaan M.M. Equine herpesvirus type 1-associated myeloencephalopathy in The Netherlands: A four-year retrospective study (1999–2003). J. Vet. Intern. Med. 2006;20:601–607.
  34. Ata E.B., Salama A., Zaghawa A., Ghazy A.A., Elsify A., Nayel M., Hegazy Y., Abdel-Rahman E.H., Warda S. Seroprevalence of equine herpes virus-1 in endemic area of Egypt with risk factors assessment. Bulg. J. Vet. Med. 2020;23:102–111.
    doi: 10.15547/bjvm.2168google scholar: lookup
  35. Henninger R.W., Reed S.M., Saville W.J., Allen G.P., Hass G.F., Kohn C.W., Sofaly C. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J. Vet. Intern. Med. 2007;21:157–165.
  36. Giessler K.S., Goehring L.S., Jacob S.I., Davis A., Esser M.M., Lee Y., Zarski L.M., Weber P.S.D., Hussey G.S. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses. J. Gen. Virol. 2024;105:001987.
    doi: 10.1099/jgv.0.001987pmc: PMC11170125pubmed: 38767608google scholar: lookup
  37. Zarski L.M., Giessler K.S., Jacob S.I., Weber P.S.D., McCauley A.G., Lee Y., Soboll Hussey G. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses. Viruses 2021;13:356.
    doi: 10.3390/v13030356pmc: PMC7995974pubmed: 33668216google scholar: lookup
  38. Dayaram A., Seeber P.A., Greenwood A.D. Environmental Detection and Potential Transmission of Equine Herpesviruses. Pathogens 2021;10:423.
    doi: 10.3390/pathogens10040423pmc: PMC8066653pubmed: 33916280google scholar: lookup
  39. Pusterla N., Wilson W.D., Mapes S., Finno C., Isbell D., Arthur R.M., Ferraro G.L. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet. J. 2009;179:230–239.
    doi: 10.1016/j.tvjl.2007.09.018pubmed: 18024200google scholar: lookup
  40. Kirsch K., Fercher C., Horstmann S., von Reitzenstein C., Augustin J., Lagershausen H. Monitoring Performance in Show Jumping Horses: Validity of Non-specific and Discipline-specific Field Exercise Tests for a Practicable Assessment of Aerobic Performance. Front. Physiol. 2022;12:818381.
    doi: 10.3389/fphys.2021.818381pmc: PMC8795742pubmed: 35095574google scholar: lookup
  41. Becker-Birck M., Schmidt A., Lasarzik J., Aurich J., Möstl E., Aurich C. Cortisol release and heart rate variability in sport horses participating in show jumping and dressage competitions. J. Vet. Behav. 2013;8:87–94.
  42. Valtonen M., Grönroos W., Luoto R., Waris M., Uhari M., Heinonen O.J., Ruuskanen O. Increased risk of respiratory viral infections in elite athletes: A controlled study. PLoS ONE 2021;16:e0250907.
  43. European Food Safety Authority (EFSA), Carvelli A., Nielsen S.S., Paillot R., Broglia A., Kohnle L. Clinical impact, diagnosis and control of Equine Herpesvirus-1 infection in Europe. EFSA J. 2022;20:e07230.
    doi: 10.2903/j.efsa.2022.7230pmc: PMC8985062pubmed: 35414834google scholar: lookup
  44. Oladunni F.S., Sarkar S., Reedy S., Balasuriya U.B.R., Horohov D.W., Chambers T.M. Equid Herpesvirus 1 Targets the Sensitization and Induction Steps to Inhibit the Type I Interferon Response in Equine Endothelial Cells. J. Virol. 2019;93:e01342-19.
    doi: 10.1128/JVI.01342-19pmc: PMC6854505pubmed: 31511388google scholar: lookup
  45. Carlson J.K., Traub-Dargatz J.L., Lunn D.P., Morley P.S., Kohler A., Kasper K., Landolt G.A., Barnett D.C., Lunn K.F. Equine viral respiratory pathogen surveillance at horse shows and sales. J. Equine. Vet. Sci. 2013;33:229–237.

Citations

This article has been cited 0 times.